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Purpose: Reconstruction of a diseased common carotid artery may necessitate direct repair via aortic artery–based
revascularization. However, carotid–carotid artery crossover grafting is an alternative extra-anatomic option that
obviates the need for median sternotomy. We analyzed our results with carotid–carotid artery crossover bypass surgery.
Methods: Data were analyzed for all patients undergoing carotid–carotid crossover bypass surgery from 1995 to 2000.
Data on patient demographics, indications for surgery, perioperative morbidity and mortality, and graft patency were
retrieved from a vascular surgery data base and hospital records. Stroke-free survival and graft patency were determined
with life table methods.
Results: Over 5 years, 24 carotid–carotid artery crossover bypass procedures were performed to treat both symptomatic
(n 19, 79%) and asymptomatic (n 5, 17%) disease. Nine procedures (38%) were performed in men, 3 (13%) in patients
with diabetes, 12 (50%) in active smokers, and 2 in patients with a history of Takayasu arteritis. Patient mean age was 63
years (range, 38-79 years). Twenty-three patients (96%) received polytetrafluoroethylene conduit grafts, and the
remaining patients received vein grafts. Ten (42%) patients underwent concomitant endarterectomy. There were no
perioperative deaths. One patient (4%) had asymptomatic early occlusion, one had transient neurologic deficit (4%), one
(4%) required additional surgery because of bleeding, and one (4%) had a perioperative cerebrovascular accident (stroke).
Three (17%) asymptomatic late occlusions were identified at 11, 57, and 64 months, respectively. Mean follow-up was 30
months (range, 1-70 months). Primary patency was 88%, and secondary patency was 92% at 3 years. Stroke-free survival
was 94% at 4 years.
Conclusion: Carotid–carotid artery crossover bypass surgery is a safe and durable procedure. Its use precludes the need for
median sternotomy and provides acceptable stroke-free survival. (J Vasc Surg 2003;37:582-5.)
Atherosclerotic occlusive disease of the great vessels can
lead to hemodynamic or embolic complications. Common
carotid, vertebrobasilar, and less frequently innominate
artery disease can lead to cerebrovascular insufficiency.
Both patients with symptomatic and asymptomatic carotid
bifurcation disease can benefit from carotid endarterecto-
my.1-5 However, only 1.5% to 2% of patients with symp-
toms have proximal carotid disease not amenable to stan-
dard carotid endarterectomy.6,7 The natural history of
common carotid artery lesions is not completely under-
stood because they are relatively rare, and in the literature
patients tend to be grouped with patients with other great
vessel disease.8 In addition to cerebrovascular insufficiency,
patients with atherosclerotic occlusive disease involving the
proximal subclavian arteries or the innominate artery may
experience microembolic events or upper extremity exer-
cise-induced ischemia. Initially, treatment of proximal
great vessel disease was performed with a direct approach to
the aortic arch.9,10 Endarterectomy and bypass grafting
were chosen as treatment options.11,12 In a review of 10
years of experience with transthoracic treatment of proxi-
mal great vessel disease, Crawford et al13 found high mor-
bidity and high mortality. Extra anatomic bypass proce-
dures have become more widely accepted because of
technical ease, decreased morbidity, and similar patency
rates. Axillary-axillary bypass grafts, subclavian-subclavian
bypass grafts, carotid-subclavian bypass grafts, carotid-ca-
rotid bypass grafts, and subclavian-carotid transposition
have been used to treat proximal great vessel disease, with
variable results.14-24 We reviewed our experience with ca-
rotid-carotid bypass procedures, specifically analyzing com-
plications, patency, operative mortality, and stroke-free
survival associated with this approach.
METHODS
From 1995 to 2000, 24 patients underwent carotid-
carotid bypass surgery. Patient demographics, indications
for intervention, perioperative morbidity and mortality,
and patency rates were retrieved from a vascular registry
data base and analyzed. All patients underwent preopera-
tive testing that included either duplex ultrasonographic
scanning or magnetic resonance imaging and four-vessel
angiography. All patients had documented either common
carotid or innominate artery stenosis or occlusions. There
were an equal number of occlusions and stenosis in these
patients.
From the Institute for Vascular Health and Disease, Albany Medical Col-
lege, Albany, NY
Competition of interest: none.
Presented at the Sixteenth Annual Meeting of the Eastern Vascular Society,
Boston, Mass, May 2-5, 2002.
Reprint requests: R. Clement Darling III, MD, Vascular Institute (MC157),
Albany Medical College, 47 New Scotland Ave, Albany, NY 12208
(e-mail: DarlinC@mail.amc.edu).
Copyright © 2003 by The Society for Vascular Surgery and The American
Association for Vascular Surgery.
0741-5214/2003/$30.00  0
doi:10.1067/mva.2003.128
582
All procedures were carried out after induction of gen-
eral anesthesia. In patients with carotid artery bifurcation
disease, eversion endarterectomy was performed in con-
junction with carotid-carotid bypass. Bypass grafts were
preferentially placed in the retroesophageal position. The
tunnel was made with careful blunt and sharp dissection on
both sides of the neck, following the plane between the
buccopharyngeal fascia and the prevertebral fascia. Once
the tunnel was made, the graft was placed, ensuring place-
ment without kinks. Polytetrafluoroethylene (PTFE) was
preferred as conduit. The bypass grafts were taken from the
donor carotid artery at the base of the neck, and the distal
anastomosis on the contralateral carotid artery was either
sewn into the common carotid artery or at the bifurcation
in patients undergoing concurrent endarterectomy. This
provided a more obliquely lying graft. No intraoperative
arterial monitoring was performed. No intraluminal shunts
were used. Although no on-table angiography was per-
formed, all bypass grafts were assessed with intraoperative
Doppler scanning.
During the postoperative period all patients were mon-
itored, specifically for blood pressure fluctuation and
change in neurologic status. After observation in the post-
anesthesia care unit, patients were transferred to the vascu-
lar surgery floor. All patients were followed up 2 weeks after
surgery. Carotid artery duplex scans were obtained at 3, 6,
and 12 months and yearly thereafter.
Classification, analysis, and reporting were performed
in accord with the criteria published by The Society for
Vascular Surgery and the International Society for Cardio-
vascular Surgry.25 Stroke-free survival and patency rates
were presented with life table methods.
RESULTS
During the 5-year study, 24 carotid–carotid artery
bypass procedures were performed in 9 men (38%) and 15
women (62%), with mean age 63 years (range, 38-79
years). Three patients (13%) had diabetes, and 12 (50%)
were active smokers. Two patients (8%) had a history of
Takayasu arteritis. Mean follow-up was 34 months (range,
1 to 70 months) (Table I).
Indications for surgery included one or a combination
of the following conditions: amaurosis fugax (n 9, 38%),
transient ischemia (n  9, 38%), asymptomatic carotid
stenosis (n  4, 17%), stroke (n  2, 8%), and subclavian
steal syndrome (n  1, 4%) (Table II). Four patients with
either transient ischemia or amaurosis fugax had a history of
concurrent upper extremity exercise-induced ischemia.
Those patients with asymptomatic carotid bifurcation ste-
nosis had concurrent inflow disease. It was believed that
decreased flow in a freshly endarterectomized artery could
possibly lead to stasis and possible thrombosis. One patient
had a neck mass, which was determined to be a pseudoan-
eurysm, after subclavian–subclavian artery bypass per-
formed at an outside institution. Two patients had under-
gone aortic artery–based reconstruction, and one patient
had undergone brachiocephalic reconstruction (Table III).
Two patients had a history of Takayasu arteritis; one had
stroke. This patient had had two previously failed aortic
artery–based reconstructions. Inflow was taken from the
left common femoral artery to the left common carotid
artery, after which left-to-right carotid artery bypass was
performed. The other patient also had a previously failed
bypass graft and new symptoms (transient ischemia) requir-
ing intervention.
Ten patients (42%) underwent carotid endarterectomy
because of concurrent carotid bifurcation disease. All of
these 10 patients had high-grade internal carotid artery
stenosis. Seven patients had symptoms referable to the side
with the carotid stenosis, but they also had a concurrent
proximal occlusion. Of the three patients with no symp-
toms who underwent carotid endarterectomy, high-grade
internal carotid artery stenosis existed at the bifurcation,
with concurrent proximal occlusions. Since the endarterec-
tomy was performed in these patients because of asymp-
tomatic carotid stenosis, it was believed that in the presence
of a proximal occlusion it would be safest to perform an
inflow procedure as well. In 23 patients (96%) 8 mm PTFE
grafts were placed, and in one patient (4%) an excised
reversed vein bypass procedure was performed (surgeon
preference).
Table I. Patient demographics
Carotid-carotid artery bypass procedures 24
Patients
Men 9
Women 9
Patient age (y)
Mean 63
Range 38-79
Takayasu arteritis 2
Diabetes 3
Smokers 12
Follow-up (mo)
Mean 34
Range 1-70
Table II. Indications for surgery
Stroke 2
Asymptomatic carotid stenosis 4
Transient ischemic attack 9
Amaurosis fugax 9
Concurrent arm claudication 4
Subclavian steal syndrome
With symptoms 1
Without symptoms (incidental finding at angiography) 5
Neck mass (pseudoaneurysm) 1
Table III. Previous surgery performed at outside
institutions
Aortic arch–based bypass graft 2
Subclavian-subclavian bypass graft (pseudoaneurysm) 1
Brachiocephalic bypass graft 1
Carotid subclavian bypass graft 1
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No patients died in the perioperative period. One pa-
tient who received a PTFE graft with concurrent carotid
endarterectomy experienced a transient neurologic event,
which completely resolved before discharge from the hos-
pital. One patient required a repeat operation for evacua-
tion of a hematoma and repair of the suture line at the distal
anastomosis. In one patient occlusion of the PTFE bypass
perioperatively required thrombectomy. The bypass graft
remained open in follow-up. One patient, who received a
PTFE graft only, had a neurologic deficit that required
rehabilitation. One patient had asymptomatic occlusion of
the PTFE graft at 11 months. Two patients had late asymp-
tomatic occlusions at 57 and 64 months, respectively (Ta-
ble IV). None of these patients experienced new symptoms,
and none underwent repeat operation. The primary pa-
tency rate at 3 years was 88%, the same as the primary
assisted patency rate (Fig 1). The secondary patency rate
was 92%. Stroke-free survival was 94% at 4 years (Fig 2).
DISCUSSION
Most patients with cerebrovascular insufficiency have
typical carotid artery bifurcation disease. A small subset of
patients have more extensive proximal disease. Treatment
of this group must result in similar morbidity and mortality
as standard endarterectomy to gain benefit from surgery.
Indications for intervention in patients with symptoms of
proximal carotid artery disease are probably more clear than
in patients without symptoms. Although most proximal
innominate and subclavian lesions are likely to be asymp-
tomatic, a small number of patients have vertebrobasilar
insufficiency, embolism, or upper extremity exertional isch-
emia requiring intervention. Results of studies in which
extra-anatomic bypass procedures were performed because
of aortic branch disease have acceptable patency rates and
comparable stroke and mortality rates.
Also of concern is that patients with aortic branch
occlusive disease may represent a population at high risk.21
As reported by Moore et al,21 85% of their patients under-
going extrathoracic bypass procedures because of great
vessel disease had coronary artery occlusive disease and
hypertensive cardiovascular disease. More than 50% of their
patients died within 5 years of surgery. The combined
stroke and death rate in patients undergoing transthoracic
repair appears to be in the range of 14% to 16%.23,26,27 On
the other hand, extra-anatomic bypass of the great vessels
can be performed with combined perioperative stroke and
death rates under 5%.23,28,29 A less invasive procedure can
clearly increase the possibility of a successful outcome with
less morbidity. Abou-Zamzam et al23 reported patency
rates as high as 90% over 5 years for extrathoracic grafts
performed specifically because of carotid artery occlusive
disease.
A theoretic concern with use of an artery as a donor is
the possibility of diminished flow to its own distal vascular
bed. However, aortic arch branches without significant
proximal disease have also been used as donor arteries
without the threat of steal, with greatly increased blood
flow supplying more than one distal vascular bed.19,20,30,31
Specifically, as suggested by Manart et al,20 carotid-carotid
bypass grafts have high flow rates, and the bypass grafts are
relatively short and are well protected from injury because
of the position of the graft deep in the neck.20 Some
authors believe that externally supported grafts may be a
better choice for cervical bypass because of fear of kink-
ing.23 Although the choice of conduit has been discussed in
the literature, there appears to be no significant difference
between prosthetic and good quality vein.23-28
Recently there has been interest in the use of endovas-
cular techniques, specifically, angioplasty and stenting, in
patients at high risk with aortic arch branch disease.32,33
Fig 1. Primary patency (SE  10% at 37-72 mo).
Fig 2. Secondary patency (SE  10% at 43-72 mo).
Table IV. Complications
Death 0
Early occlusion (thrombectomy, postoperative day 1) 1
Late occlusion (one each at 11, 57, and 64 mo) 3
Transient neurologic deficit 1
Bleeding (anastomosis repair, evacuation of hematoma) 1
Stroke (postoperative) 1
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The long-term outcome of these procedures remains to be
seen. Recently, in a study by Arko et al,34 proximal carotid
artery angioplasty and stenting was performed with concur-
rent carotid endarterectomy. Six patients underwent com-
bined endovascular and surgical interventions, with fol-
low-up ranging from 6 to 43 months. In very early
follow-up no patients had restenosis; however, long-term
results have yet to be reported. Recently all patients at our
institution have been evaluated for possible endovascular
intervention. However, some patients have unfavorable
anatomy and require surgical intervention. In addition, if
an endovascular procedure has already been undertaken
and has failed, extra-anatomic bypass grafting certainly
could be considered as a safe and effective secondary pro-
cedure. There has been a recent case report by Kumins et
al35 in which restenosis of a carotid lesion occurred after
angioplasty and stenting, requiring an internal carotid-
carotid transposition.
In patients with aortic branch disease, extra-anatomic
bypass procedures are safe and durable. In this series,
patients both with and without symptoms with bifurcation
disease and concurrent inflow disease, patients with proxi-
mal disease with symptoms, patients with Takayasu arteritis
with cerebrovascular insufficiency, and a patient with a graft
infection underwent carotid–carotid artery bypass proce-
dures, with favorable outcome and acceptable risk.
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